PMID: 7523242May 1, 1994Paper

Immunosuppressive agents in chronic severe asthma

Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
A B Kay

Abstract

Previous immunosuppressive agents utilized as therapies for immune system mediated diseases such as chronic allergic asthma, and rheumatoid arthritis include purine antagonists, methotrexate, and gold salts. These treatment modalities have been shown to elicit either limited treatment efficacy or to produce undesirable side effects in many individuals. Cyclosporin A is a potent immunosuppressive agent which appears to arrest division of T lymphocytes and inhibit mediator release from mast cells. However, like other immunosuppressive agents, cyclosporin A may also produce many potentially serious side effects; among these is the possibility of irreversible renal damage. Nephrotoxicity can be attenuated, because renal pathological changes seem to be high cumulative dose-related. If whole blood levels of cyclosporin A are maintained between 200 and 500 ng/mL, serious renal toxicity is unusual. Investigation of cyclosporin A in individuals who have severe long-term corticosteroid-dependent chronic asthma has demonstrated the efficacy of this agent, resulting in clinically significant improvement in pulmonary function. Therefore, it can be hypothesized that T lymphocytes may act as effector cells in cell-mediated hypersensitivity re...Continue Reading

Citations

May 18, 2001·ANZ Journal of Surgery·N C Hatrick, M A Tonkin
Jul 1, 1996·Inflammatory Bowel Diseases·R Eliakim, D Rachmilewitz
Feb 4, 1998·Veterinary Surgery : VS·J DahlingerJ Bea
May 23, 2002·Journal of the American Animal Hospital Association·Jenise C Daigle
Feb 6, 2008·The Journal of Veterinary Medical Science·Masaaki KatayamaMasahiro Tagawa
Jun 13, 2014·Current Opinion in Pharmacology·Nastasia V WasilewskiJohn T Fisher
Jul 17, 2001·American Journal of Veterinary Research·J C DaigleR P Hunter
May 6, 2010·Pharmacoepidemiology and Drug Safety
Feb 7, 2004·Pharmacoepidemiology and Drug Safety
Feb 20, 2004·Pharmacoepidemiology and Drug Safety
Dec 17, 2008·Pharmacoepidemiology and Drug Safety
May 18, 2021·Journal of Asthma and Allergy·Cai-Tao ChenYong-Qing Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

The Journal of Hand Surgery : Journal of the British Society for Surgery of the Hand
M PetrolatiC Guerriero
Digestive Diseases and Sciences
M D Schuffler, S Krishnamurthy
© 2021 Meta ULC. All rights reserved